Key Points for Designing and Reporting Helicobacter pylori Therapeutic Trials: A Personal View
- 19 September 2011
- journal article
- Published by Wiley in Helicobacter
- Vol. 16 (5) , 346-355
Abstract
Background & objectives: The aim of this document is to provide a methodological framework and to review key aspects for adequately designing trials to evaluate new treatments for Helicobacter pylori infection. Methods: Non-systematic literature review. Results & conclusions: Regarding the design of the article, we suggest selecting for future trials drugs to which H. pylori has no significant primary resistances and evaluating therapies with pilot studies before engaging in randomized trials. The manuscript defines how the number and type of H. pylori diagnostic tests necessary before and after the trial depend on the setting and reliability of the tests. It recommends the best methods and timing for H. pylori testing before and after therapy. Other recommendations are using current standard treatments as comparators of new therapies, determining antibiotic sensitivity – whenever useful and possible – using adequate randomization and allocation concealment but not necessarily blinding, and performing an intention-to-treat and a per-protocol analysis. In addition, we give basic tips for reporting and discussing study results.Keywords
This publication has 41 references indexed in Scilit:
- Analysis of drug resistance and virulence‐factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?Alimentary Pharmacology & Therapeutics, 2009
- Accuracy of Diagnostic Tests forHelicobacter pylori:A ReappraisalClinical Infectious Diseases, 2009
- Meta‐analysis: Four‐Drug, Three‐Antibiotic, Non‐bismuth‐Containing “Concomitant Therapy” Versus Triple Therapy for Helicobacter pylori EradicationHelicobacter, 2009
- Efficient Identification and Evaluation of Effective Helicobacter pylori TherapiesClinical Gastroenterology and Hepatology, 2009
- Helicobacter pylori and antibiotic resistanceGut, 2007
- The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysisGut, 2007
- Evaluation of the Novel Helicobacter pylori ClariRes Real-Time PCR Assay for Detection and Clarithromycin Susceptibility Testing of H. pylori in Stool Specimens from Symptomatic ChildrenJournal of Clinical Microbiology, 2007
- Recurrence of Helicobacter pylori infection after several eradication therapies: long‐term follow‐up of 1000 patientsAlimentary Pharmacology & Therapeutics, 2006
- The Recurrence of Helicobacter pylori Infection: Incidence and Variables Influencing It. A Critical ReviewAmerican Journal of Gastroenterology, 2005
- H pylori antibiotic resistance: prevalence, importance, and advances in testingGut, 2004